Physiological separation of Alzheimer's disease and Alzheimer's disease with significant levels of cerebrovascular symptomology and healthy controls

被引:11
|
作者
Lithgow, Brian J. [1 ,2 ]
Dastgheib, Zeinab [1 ]
Anssari, Neda [3 ]
Mansouri, Behzad [1 ,3 ]
Blakley, Brian [4 ]
Ashiri, Mehrangiz [1 ]
Moussavi, Zahra [1 ]
机构
[1] Univ Manitoba, Riverview Hlth Ctr, Diagnost & Neurosignal Proc Res Lab, Biomed Engn Program, Winnipeg, MB, Canada
[2] Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia
[3] Brain Vis & Concuss Clin iScope, Vis Matter Res Ins, Winnipeg, MB, Canada
[4] Hlth Sci Ctr, Dept Otolaryngol, Winnipeg, MB, Canada
关键词
Alzheimer's disease; Cerebrovascular symptomatology; Mixed dementia; Vascular dementia; Electrovestibulography; Biomarkers; MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; CLINICAL-DIAGNOSIS; NATIONAL INSTITUTE; DEMENTIA; STIMULATION; PERFORMANCE; PROGRESSION; RECEPTORS;
D O I
10.1007/s11517-021-02409-8
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Most dementia patients with a mixed dementia (MxD) diagnosis have a mix of Alzheimer's disease (AD) and vascular dementia. Electrovestibulography (EVestG) records vestibuloacoustic afferent activity. We hypothesize EVestG recordings of AD and MxD patients are different. All patients were assessed with the Montreal cognitive assessment (MoCA) and Hachinski ischemic scale (HIS) (>4 HIS score <7 is representative of MxD cerebrovascular symptomology). EVestG recordings were made from 26 AD, 21 MxD and 44 healthy (control) participants. Features were derived from the EVestG recordings of the average field potential and field potential interval histogram to classify the AD, MxD and control groups. Multivariate analysis was used to test the features' significance. Using a leave-one-out cross-validated linear discriminant analysis with 3 EVestG features yielded accuracies > 80% for separating pairs of AD/MxD/control. Using the MoCA assessment and 2 EVestG features, a best accuracy of 81 to 91% depending on the classifier was obtained for the 3-way identification of AD, MxD and controls. EVestG measures provide a physiological basis for identifying AD from MxD. EVestG measures are hypothesized to be partly related to channelopathies and changes in the descending input to the vestibular periphery. Four of the five AD or MxD versus control features used had significant correlations with the MoCA. This supports assertions that the pathologic changes associated with AD impact the vestibular system and further are suggestive that the postulated physiological changes behind these features have an association with cognitive decline severity.
引用
收藏
页码:1597 / 1610
页数:14
相关论文
共 50 条
  • [21] Cerebrovascular lesions in Alzheimer's disease
    Sharma, J. C.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (02) : 182 - 183
  • [22] Morphometric characterization of Binswanger's disease: Comparison with Alzheimer's disease
    Shiino, Akihiko
    Akiguchi, Ichiro
    Watanabe, Toshiyuki
    Shirakashi, Yoshitomo
    Nozaki, Kazuhiko
    Tooyama, Ikuo
    Inubushi, Toshiro
    EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (09) : 2375 - 2379
  • [23] Cerebrovascular disease promotes tau pathology in Alzheimer's disease
    Laing, Krystal K.
    Simoes, Sabrina
    Baena-Caldas, Gloria P.
    Lao, Patrick J.
    Kothiya, Milankumar
    Igwe, Kay C.
    Chesebro, Anthony G.
    Houck, Alexander L.
    Pedraza, Lina
    Hernandez, A. Ivan
    Li, Jie
    Zimmerman, Molly E.
    Luchsinger, Jose A.
    Barone, Frank C.
    Moreno, Herman
    Brickman, Adam M.
    BRAIN COMMUNICATIONS, 2020, 2 (02)
  • [24] Sulcal Span in Alzheimer's Disease, Amnestic Mild Cognitive Impairment, and Healthy Controls
    Reiner, Peggy
    Jouvent, Eric
    Duchesnay, Edouard
    Cuingnet, Remi
    Mangin, Jean-Francois
    Chabriat, Hugues
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 29 (03) : 605 - 613
  • [25] On the reconceptualization of Alzheimer's disease
    Schermer, Maartje H. N.
    Richard, Edo
    BIOETHICS, 2019, 33 (01) : 138 - 145
  • [26] Progress in Alzheimer's disease
    Galimberti, Daniela
    Scarpini, Elio
    JOURNAL OF NEUROLOGY, 2012, 259 (02) : 201 - 211
  • [27] Cerebrovascular medin is associated with Alzheimer's disease and vascular dementia
    Migrino, Raymond Q.
    Karamanova, Nina
    Truran, Seth
    Serrano, Geidy E.
    Davies, Hannah A.
    Madine, Jillian
    Beach, Thomas G.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)
  • [28] Biomarkers in Alzheimer's disease
    Demarin, Vida
    Zavoreo, Iris
    Kes, Vanja Basic
    Simundic, Ana Marija
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (05) : 773 - 778
  • [29] Biomarkers in Alzheimer's disease
    Garcia-Ribas, Guillermo
    Lopez-Sendon Moreno, Jose Luis
    Garcia-Caldentey, Juan
    REVISTA DE NEUROLOGIA, 2014, 58 (07) : 308 - 317
  • [30] Update: Alzheimer's Disease
    Reich, A.
    Schulz, J. B.
    AKTUELLE NEUROLOGIE, 2011, 38 (05) : 234 - 241